Effect of chronic central administration of glucagon-like peptide-1 (7-36) amide on food consumption and body weight in normal and obese rats

Obesity Research

Volumn 6, Issue 2, 1998, Pages 147-156

  Davis Jr , Harry R ^a   Mnllins, Deborra E ^a   Pines, Jesse M ^a   Hoos, Lizbeth M ^a   France, Constance F ^a   Compton, Douglas S ^a   Graziano, Michael P ^a   Sybertz, Edmund J ^a   Strader, Catherine D ^a   Van Heek, Margaret ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

GLP 1; Obesity; Receptor desensitization; Zucker (fa fa) rats

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; GLUCAGON; GLUCAGON LIKE PEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 (7 36)AMIDE; GLUCAGON LIKE PEPTIDE RECEPTOR; GLUCAGON RECEPTOR; GLUCAGON-LIKE PEPTIDE 1 (7-36)AMIDE; GLUCAGON-LIKE PEPTIDE RECEPTOR; PEPTIDE FRAGMENT;

ANIMAL; ARTICLE; BODY WEIGHT; CELL CULTURE; DRUG EFFECT; EATING; INSULINOMA; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; METABOLISM; OBESITY; PANCREAS TUMOR; PATHOPHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; ZUCKER RAT;

ANIMALS; BODY WEIGHT; EATING; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDES; INJECTIONS, INTRAVENTRICULAR; INSULINOMA; MALE; NEUROTRANSMITTER AGENTS; OBESITY; PANCREATIC NEOPLASMS; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; RATS, ZUCKER; RECEPTORS, GLUCAGON; TUMOR CELLS, CULTURED;

EID: 0032010997     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1550-8528.1998.tb00329.x     Document Type: Article

References (9)

1. Broderick CL, Heisserman JA, Smiley DL, Miller AR. Effect of sub-chronic administration of CLIP (7-37) OH on beta cell failure in Zucker diabetic rats. Diabetologia. 1995; 38(Suppl 1):A171.
2. Drucker DJ, Asa S. Glueagon gene expression in vertebrate brain. J Biol Cliem. 1988;263:13475-13478.
3. Gokc R, Larsen PJ, Mikkelsen JD, Sheikh SP. Distribution of GLP-1 binding sites in the rat brain: Evidence that exen-din-4 is a ligand of brain GLP-1 binding sites. Ear J Neurosci. 1995;7:2294-2300.
4. Gunn I, O'Shea D, Turton MD, Beak SA, Bloom SR. A role for glucagon-like peptide-1 in the central regulation of feeding. Biochem Soc Trans. 1996;24:581-584.
5. Gutniak M, Orskov C, Holst JJ, Ahren B, Efendic S. Antidiabetogenic effect of glucagon-like peptide-1 (7-36) amide in normal subjects and patients with diabetes. N Engl J Med. 1992:326:1316-1322.
6. Han VKM, Hynes MA, Jin C, Towle AC, Lauder JM, Lund PK. Cellular localization of proglucagon/glucagon-like peptide 1 messenger RNAs in rat brain. J Neurosci Res. 1986;16:97-107.
7. Hargrove DM, Nardone NA, Persson LM, Parker JC. Effects of chronic and acute administration of glucagon-like peptide-1 (7-37) [GLP] on glucose stimulated insulin secretion in vivo. Diabetes 1994;43(Suppl 1):161A.
8. Hwa J, Fawzi A, Graziano MP, et al. Leptin increases thermogenesis and selectively promotes fat metabolism in ob/ob mice. Am J Physiol. 1997;272:R1204-R1209.
9. Jin S-LC, Han VKM, Simmons JG, Towle AC, Lauder JM, Lund PK. Distribution of glucagon-like peptide 1 (GLP1), glucagon, and glicentin in the rat brain: An immunocytochemical study. J Comp Neural. 1988;271:519-532.